Coronavirus disease 2019 (COVID-19) is responsible for the ongoing pandemic associated with significant morbidity and mortality around the globe.1,2 Vaccines based on a broad range of different technologies have proven highly effective at preventing symptomatic disease and death and have played an essential role in flattening the epidemiology curve.1,2 Nevertheless, some concerns have been raised due to rare cases of myocarditis and pericarditis following the receipt of COVID-19 vaccine, especially mRNA vaccines.
Filling the gap in epidemiology, management and clinical course of COVID-19 vaccination-related pericarditis
Aldostefano Porcari
2022-01-01
Abstract
Coronavirus disease 2019 (COVID-19) is responsible for the ongoing pandemic associated with significant morbidity and mortality around the globe.1,2 Vaccines based on a broad range of different technologies have proven highly effective at preventing symptomatic disease and death and have played an essential role in flattening the epidemiology curve.1,2 Nevertheless, some concerns have been raised due to rare cases of myocarditis and pericarditis following the receipt of COVID-19 vaccine, especially mRNA vaccines.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Porcari - Filling the gap - Journal of Cardiovascular Medicine.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
561.1 kB
Formato
Adobe PDF
|
561.1 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
Porcari+-+Filling+the+gap+-+Journal+of+Cardiovascular+Medicine-Post_print.pdf
Open Access dal 24/09/2023
Tipologia:
Bozza finale post-referaggio (post-print)
Licenza:
Creative commons
Dimensione
1.07 MB
Formato
Adobe PDF
|
1.07 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
